Tumours switch to resist

Antoni Ribas () and Paul C. Tumeh
Additional contact information
Antoni Ribas: Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California 90095-1782, USA.
Paul C. Tumeh: Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California 90095-1782, USA.

Nature, 2012, vol. 490, issue 7420, 347-348

Abstract: Tumour cells can respond to targeted immune-cell therapies by losing proteins that mark them as being cancerous. Subverting this resistance mechanism may lead to more durable cancer-treatment strategies. See Letter p.412

Date: 2012
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/nature11489 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:490:y:2012:i:7420:d:10.1038_nature11489

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature11489

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().